Common name
2-ethyl-1H-imidazole
IUPAC name
2-ethyl-1H-imidazole
SMILES
CCc1[nH]ccn1
Common name
2-ethyl-1H-imidazole
IUPAC name
2-ethyl-1H-imidazole
SMILES
CCc1[nH]ccn1
INCHI
InChI=1S/C5H8N2/c1-2-5-6-3-4-7-5/h3-4H,2H2,1H3,(H,6,7)
FORMULA
C5H8N2
Common name
2-ethyl-1H-imidazole
IUPAC name
2-ethyl-1H-imidazole
Molecular weight
96.130
clogP
1.742
clogS
-1.638
Frequency
0.0017
HBond Acceptor
1
HBond Donor
1
Total PolarSurface Area
28.68
Number of Rings
1
Rotatable Bond
1
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00736 | Eprosartan |
|
Cardiovascular System; Angiotensin II Antagonists, Plain; Agents Acting on the Renin-Angiotensin System; Angiotensin II Antagonists and Diuretics; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Angiotensin II Receptor Antagonists; | For the management of hypertension alone or in combination with other classes of antihypertensive agents. Also used as a first-line agent in the treatment of diabetic nephropathy, as well as a second-line agent in the treatment of congestive heart failure (only in those intolerant of ACE inhibitors). |
| FDBD01147 | Saprisartan |
|
Angiotensin II Receptor Antagonists; | Saprisartan is used in the treatment of hypertension and heart failure. |
| FDBD01353 | Lofexidine |
|
Antihypertensive Agents; Adrenergic alpha-2 Receptor Agonists; Narcotic Antagonists; Nervous System; Drugs Used in Addictive Disorders; Drugs Used in Opioid Dependence; Alpha2 Agonists; | Investigated for use/treatment in addictions and substance abuse. |
| FDBD01773 | Eluxadoline |
|
Gastrointestinal Agents; | For the treatment of irritable bowel syndrome with diarrhea (IBS-D). |
| FDBD03129 | glyodin |
|
Fungicide | Fungicide |
5 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4yqh_ligand_2_3.mol2 | 4yqh | 1 | -6.01 | C(C)c1[nH+]cc[nH]1 | 7 |
| 2vev_ligand_2_16.mol2 | 2vev | 1 | -5.49 | C(C)c1[nH+]cc[nH]1 | 7 |
| 2veu_ligand_2_14.mol2 | 2veu | 1 | -5.46 | C(C)c1[nH+]cc[nH]1 | 7 |
| 4x6p_ligand_2_11.mol2 | 4x6p | 1 | -5.42 | [nH+]1cc[nH]c1CC | 7 |
| 4ty6_ligand_2_14.mol2 | 4ty6 | 1 | -5.40 | C(C)c1[nH+]cc[nH]1 | 7 |
| 2vew_ligand_2_14.mol2 | 2vew | 1 | -5.39 | CCc1[nH+]cc[nH]1 | 7 |
| 2vex_ligand_2_16.mol2 | 2vex | 1 | -5.39 | C(C)c1[nH+]cc[nH]1 | 7 |
| 2vey_ligand_2_18.mol2 | 2vey | 1 | -5.38 | CCc1[nH+]cc[nH]1 | 7 |
206 ,
21
